The review identifies key challenges including mechanical strength limitations, sterility concerns, and the need for improved bioprinting resolution and vascularization.
Gels · 4 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The review identifies key challenges including mechanical strength limitations, sterility concerns, and the need for improved bioprinting resolution and vascularization.
The review identifies critical limitations: synthetic hydrogels lack cell-specific bioactivities such as cell adhesion and biodegradation; mechanical strength (compressive, tensile, shear thinning) remains insufficient for clinical applications; and sterility throughout the manufacturing process is unresolved. For bioprinting tissues, vascularization beyond 100–200 micrometers diffusion limits remains a major barrier. The authors conclude that while hydrogels show promise for biosensors, drug delivery, and tissue engineering, further development of precursor materials, crosslinking mechanisms, and printing parameters is needed for clinical translation.